Driving Next Generation Immuno-Oncology Innovation for Cancer Treatment
Immuno-oncology (IO) takes advantage of the body’s immune system to prevent, control, and eliminate cancer and dates as far back as the 1890s, after a doctor purposely infected a man suffering from an inoperable malignant tumor with bacteria, resulting in his recovery[i].
Driven in part by the increasing number of biotechs and companies that are conducting IO clinical trials in China and the Asia Pacific—and the higher prevalence of cancers in Asia with high somatic mutations such as melanoma, lung cancer, bladder cancer, stomach and esophageal cancer which are known to be more sensitive to IO therapies—the IO market in the region is expected to increase from roughly US$15 billion in 2019 to an estimated US$28 billion by the end of 2024[ii].
When scouting for oncology innovation globally, we focus on the key strengths of each region. So, how can we complement Asia’s strengths in oncology? Join us in this webinar as we hear from experts from across the Johnson & Johnson Family of Companies on our IO/oncology external innovation strategy and how we work with early-stage companies in a flexible co-collaboration model.
Please note: This webinar will be a rebroadcast of the recording which took place June 23, 2021.
You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email [email protected]
DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.